Skip to content

Clinical trials

Lung Neoplasms trials in Canada with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Not applicable Country / region: Canada Clear all

78 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20063
20083
20092
20102
20112
20122
20138
20142
20155
20161
20178
20186
20195
20203
20211
20224
20239
20242
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41
Unknown status10
Recruiting8
Terminated8
Active, not recruiting5
Withdrawn3
Not yet recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto15
Centre hospitalier de l'Université de Montréal (CHUM)13
McMaster University5
Laval University4
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval3
St. Joseph's Healthcare Hamilton3
University of Calgary3
British Columbia Cancer Agency2
McGill University Health Centre/Research Institute of the McGill University Health Centre2
Sunnybrook Health Sciences Centre2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms78
Carcinoma, Non-Small-Cell Lung13
Breast Neoplasms6
Neoplasms5
Prostatic Neoplasms3
Colonic Neoplasms2
Disease2
Lung Diseases2
Lymphoma2
Neoplasm Metastasis2

Trials

Showing 1 to 25 of 78. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.